|Articles|January 27, 2022
Supplements and Featured Publications
- The Underrecognized Burden of Atopic Dermatitis in the United States
The Underrecognized Burden of Atopic Dermatitis in the United States
Advertisement
This publication is sponsored by AbbVie Inc.
This Clinical Brief provides an overview of the complex pathogenesis, heavy burden, and limited diagnostic, staging, and therapeutic options available for more severe atopic dermatitis.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5
